ProfileGDS4718 / 232810_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 27% 22% 20% 21% 23% 34% 28% 21% 14% 16% 27% 14% 21% 38% 31% 21% 22% 35% 34% 22% 25% 16% 16% 22% 15% 33% 20% 48% 35% 23% 28% 44% 15% 15% 35% 48% 29% 20% 18% 20% 19% 29% 27% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4101627
GSM549102patient 115, normal, homogenized [OPG study]4.2478822
GSM549104patient 119, normal, homogenized [OPG study]4.1168220
GSM549108patient 138, normal, homogenized [OPG study]4.2205621
GSM549119patient 077, normal, homogenized [OPG study]4.2490323
GSM549133patient 032, cancer, homogenized [OPG study]4.6408434
GSM549139patient 042, cancer, homogenized [OPG study]4.4526828
GSM549099patient 107, normal, homogenized [OPG study]4.1841221
GSM549109patient 139, normal, homogenized [OPG study]3.9501314
GSM549110patient 046, normal, homogenized [OPG study]4.0093216
GSM549114patient 063, normal, homogenized [OPG study]4.3752627
GSM549122patient 082, normal, homogenized [OPG study]3.9459814
GSM549134patient 033, cancer, homogenized [OPG study]4.1859521
GSM549136patient 036, cancer, homogenized [OPG study]4.8525538
GSM549140patient 044, cancer, homogenized [OPG study]4.5301231
GSM549111patient 047, normal, homogenized [OPG study]4.1732121
GSM549113patient 057, normal, homogenized [OPG study]4.1653922
GSM549132patient 031, cancer, homogenized [OPG study]4.7277635
GSM549137patient 038, cancer, homogenized [OPG study]4.6904134
GSM549142patient 047, cancer, homogenized [OPG study]4.3336622
GSM549100patient 110, normal, homogenized [OPG study]4.3452725
GSM549107patient 135, normal, homogenized [OPG study]3.9825316
GSM549115patient 068, normal, homogenized [OPG study]3.9704416
GSM549116patient 072, normal, homogenized [OPG study]4.2102422
GSM549120patient 078, normal, homogenized [OPG study]3.9607315
GSM549131patient 030, cancer, homogenized [OPG study]4.6177733
GSM549118patient 074, normal, homogenized [OPG study]4.1330220
GSM549129patient 027, cancer, homogenized [OPG study]5.4485448
GSM549123patient 088, normal, homogenized [OPG study]4.7216235
GSM549124patient 006, cancer, homogenized [OPG study]4.2989823
GSM549126patient 015, cancer, homogenized [OPG study]4.4513528
GSM549128patient 025, cancer, homogenized [OPG study]5.1875644
GSM549103patient 117, normal, homogenized [OPG study]3.99515
GSM549117patient 073, normal, homogenized [OPG study]3.9554415
GSM549138patient 041, cancer, homogenized [OPG study]4.7356835
GSM549141patient 045, cancer, homogenized [OPG study]5.3604148
GSM549130patient 028, cancer, homogenized [OPG study]4.5004329
GSM549101patient 111, normal, homogenized [OPG study]4.1474220
GSM549105patient 128, normal, homogenized [OPG study]4.0830118
GSM549106patient 134, normal, homogenized [OPG study]4.1021620
GSM549112patient 048, normal, homogenized [OPG study]4.1036219
GSM549125patient 011, cancer, homogenized [OPG study]4.4906929
GSM549127patient 024, cancer, homogenized [OPG study]4.4203727
GSM549135patient 035, cancer, homogenized [OPG study]5.1198344